339 related articles for article (PubMed ID: 19449455)
1. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.
Chessa M; Colombo C; Butera G; Negura D; Piazza L; Varotto L; Bussadori C; Fesslova V; Meola G; Carminati M
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):401-5. PubMed ID: 19449455
[TBL] [Abstract][Full Text] [Related]
2. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
[TBL] [Abstract][Full Text] [Related]
3. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache.
Khessali H; Mojadidi MK; Gevorgyan R; Levinson R; Tobis J
JACC Cardiovasc Interv; 2012 Jun; 5(6):682-7. PubMed ID: 22721665
[TBL] [Abstract][Full Text] [Related]
4. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
5. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
Shi YJ; Lv J; Han XT; Luo GG
BMC Cardiovasc Disord; 2017 Jul; 17(1):203. PubMed ID: 28747203
[TBL] [Abstract][Full Text] [Related]
6. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
7. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
10. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine.
Elbadawi A; Barssoum K; Abuzaid AS; Rezq A; Biniwale N; Alotaki E; Mohamed AH; Vuyyala S; Ogunbayo GO; Saad M
Acta Cardiol; 2019 Apr; 74(2):124-129. PubMed ID: 29914296
[TBL] [Abstract][Full Text] [Related]
12. [Migraine and patent foramen ovale].
Lucas C
Rev Neurol (Paris); 2013 May; 169(5):390-6. PubMed ID: 23602120
[TBL] [Abstract][Full Text] [Related]
13. Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More.
Altamura C; Paolucci M; Costa CM; Brunelli N; Cascio Rizzo A; Cecchi G; Vernieri F
Cerebrovasc Dis; 2019; 47(5-6):268-274. PubMed ID: 31357200
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale and migraine.
Post MC; Luermans JG; Plokker HW; Budts W
Catheter Cardiovasc Interv; 2007 Jan; 69(1):9-14. PubMed ID: 17143907
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study.
Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G
J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904
[TBL] [Abstract][Full Text] [Related]
16. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
19. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.
Anzola GP; Frisoni GB; Morandi E; Casilli F; Onorato E
Stroke; 2006 Feb; 37(2):430-4. PubMed ID: 16373630
[TBL] [Abstract][Full Text] [Related]
20. Migraine and patent foramen ovale: exploring the association and a possible treatment option.
Hasan MY
J Pak Med Assoc; 2008 Aug; 58(8):453-5. PubMed ID: 18822645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
